Diseases, Conditions, Syndromes

Study details changes in Omicron's spike protein

An international team of scientists has determined the precise structural changes in the spike protein of the omicron variant. Their observations explain how the virus is able to evade antibodies against previous variants ...

Diseases, Conditions, Syndromes

Breakthrough infections spur strong antibody responses 

A recent study looked at the strength, durability and breadth of neutralizing antibody responses generated by breakthrough infections in individuals vaccinated against SARS-CoV2.

Diseases, Conditions, Syndromes

Study: Omicron evades some but not all monoclonal antibodies

Several, but not all, of the human monoclonal antibodies used clinically to prevent patients from becoming severely ill from COVID-19 may not be protective against the omicron variant now sweeping across the United States, ...

Diseases, Conditions, Syndromes

Persistent T cell response to omicron after infection and vaccination

The omicron variant can partly evade the antibody response provided by vaccination or infection with previous variants of SARS-CoV-2. However, T cells still recognize omicron, scientists at Karolinska Institutet in Sweden ...

Oncology & Cancer

Two antibodies synergize in triple whammy to pediatric cancers

A combination of anti-cancer antibodies produced a powerfully synergistic response in two hard-to-treat pediatric cancers, according to a new study, in mice, led by researchers at the Stanford University School of Medicine.

Diseases, Conditions, Syndromes

Antibodies in blood soon after COVID-19 onset may predict severity

Blood drawn from patients shortly after they were infected with SARS-CoV-2, the virus that causes COVID-19, may indicate who is most likely to land in the hospital, a study led by Stanford Medicine investigators has found.

page 27 from 40